Old Web
English
Sign In
Acemap
>
authorDetail
>
Daphne Williams
Daphne Williams
GlaxoSmithKline
Pharmacology
Medicine
Thrombopoietin receptor
Agonist
Eltrombopag
4
Papers
295
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia
2013
Cancer Chemotherapy and Pharmacology
Siobhan Hayes
Paul N. Mudd
Daniele Ouellet
Brendan M. Johnson
Daphne Williams
Ekaterina Gibiansky
Show All
Source
Cite
Save
Citations (18)
Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis
2010
European Journal of Clinical Pharmacology
Julian Jenkins
Daphne Williams
Yanli Deng
David Collins
Valerie S. Kitchen
Show All
Source
Cite
Save
Citations (13)
A Bayesian population PK–PD model for ispinesib/docetaxel combination-induced myelosuppression
2009
Cancer Chemotherapy and Pharmacology
S. Kathman
Daphne Williams
Jeffrey P. Hodge
Mohammed M. Dar
Show All
Source
Cite
Save
Citations (14)
Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist
2007
Blood
Julian Jenkins
Daphne Williams
Yanli Deng
Joanne Uhl
Valerie S. Kitchen
David Collins
Connie L. Erickson-Miller
Show All
Source
Cite
Save
Citations (250)
1